Figure 1D illustrates the results of the upstream regulator analysis (top 10 candidates), predicting interleukin (IL)-17A as the leading upstream molecule associated with the proteins elevated in patients with high risk of PAH. The gene discussed is IL17A; the disease is pulmonary arterial hypertension.